From: A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial
Day
Number of Sprays
Morning
Between waking-up and 12pm
Afternoon
Between 4pm and bedtime
Total number of sprays per day
1
0
2
3
4
5
6
7
8
9
10
11
12
13
14